Antrodia and Metabolic Health
Explore mushroom research and guides on antrodia and metabolic health.
Antrodia camphorata and AMPK-Driven Fat Oxidation
Antrodia camphorata triterpenoids activate AMPK and boost fat oxidation in preclinical models. Antcin K, eburicoic acid, and dehydroeburicoic acid reviewed.
Antrodia camphorata and Blood Sugar Research
Antrodia camphorata triterpenoids lower blood glucose via GLUT4 translocation, insulin secretion, and gluconeogenesis suppression in preclinical studies.
Antrodia camphorata and Cholesterol Research
Antrodia cinnamomea reduced total cholesterol 5.7% in men in an uncontrolled pilot study. Two randomized trials moved triglycerides and liver fat. No indexed trial has reported LDL.
Antrodia and Metabolic Syndrome Research
Antrodia camphorata triterpenoids target blood sugar, cholesterol, obesity, and fatty liver in animal models. Review of 8 preclinical studies and key compounds.
Antrodia for Obesity: Anti-Adipogenic Research
Antrodia camphorata reduces body weight, fat accumulation, and adipocyte differentiation through PPARγ, AMPK, and SREBP pathways in preclinical models.